8YPA | pdb_00008ypa

Human mitochondrial ClpP in complex with TR89

PDB DOI: https://doi.org/10.2210/pdb8YPA/pdb

Classification: HYDROLASE
Organism(s): Homo sapiens
Expression System: Escherichia coli
Mutation(s): No

Deposited: 2024-03-16 Released: 2025-03-19
Deposition Author(s): Li, Q.-N., Sun, H.-Y., Xiao, Y.-B.
Funding Organization(s): Not funded

Experimental Data Snapshot

Method: X-RAY DIFFRACTION
Resolution: 2.67 Å
R-Value Free:
0.258 (Depositor), 0.256 (DCC)
R-Value Work:
0.215 (Depositor), 0.214 (DCC)
R-Value Observed:
0.216 (Depositor)

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Ligand Structure Quality Assessment

This is version 1.0 of the entry. See complete history.

Literature

Human mitochondrial ClpP in complex with TR89

Li, Q.-N., Sun, H.-Y., Xiao, Y.-B.

To be published.

Macromolecule Content

Total Structure Weight: 173.53 kDa
Atom Count: 9,773
Modeled Residue Count: 1,248
Deposited Residue Count: 1,561
Unique protein chains: 1

Macromolecules

Find similar proteins by:

(by identity cutoff) | 3D Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
ATP-dependent Clp protease proteolytic subunit, mitochondrial	A, B, C, D, E A, B, C, D, E, F, G	223	Homo sapiens	Mutation(s): 0 Gene Names: CLPP EC: 3.4.21.92
UniProt & NIH Common Fund Data Resources
Find proteins for Q16740 (Homo sapiens) Explore Q16740 Go to UniProtKB: Q16740
PHAROS: Q16740 GTEx: ENSG00000125656
Entity Groups
Sequence Clusters	30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt Group	Q16740
Sequence Annotations Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram	3D Interactions
A1LZN (Subject of Investigation/LOI) Query on A1LZN Download Ideal Coordinates CCD File SDF format, chain N [auth G] SDF format, chain M [auth F] SDF format, chain L [auth D] SDF format, chain K [auth D] SDF format, chain J [auth C] SDF format, chain I [auth B] SDF format, chain H [auth A] MOL2 format, chain N [auth G] MOL2 format, chain M [auth F] MOL2 format, chain L [auth D] MOL2 format, chain K [auth D] MOL2 format, chain J [auth C] MOL2 format, chain I [auth B] MOL2 format, chain H [auth A] mmCIF format, chain N [auth G] mmCIF format, chain M [auth F] mmCIF format, chain L [auth D] mmCIF format, chain K [auth D] mmCIF format, chain J [auth C] mmCIF format, chain I [auth B] mmCIF format, chain H [auth A]	H [auth A] I [auth B] J [auth C] K [auth D] L [auth D] H [auth A], I [auth B], J [auth C], K [auth D], L [auth D], M [auth F], N [auth G]	(6~{R})-2-[[3,5-bis(fluoranyl)phenyl]methyl]-6-(hydroxymethyl)-5-[[4-(trifluoromethyl)phenyl]methyl]-7,8-dihydro-6~{H}-pyrazolo[1,5-a][1,4]diazepin-4-one C₂₃ H₂₀ F₅ N₃ O₂ SZLZNFDCRGBJIA-UHFFFAOYSA-N		Interactions Focus chain H [auth A] Focus chain I [auth B] Focus chain J [auth C] Focus chain K [auth D] Focus chain L [auth D] Focus chain M [auth F] Focus chain N [auth G] Interactions & Density Focus chain H [auth A] Focus chain I [auth B] Focus chain J [auth C] Focus chain K [auth D] Focus chain L [auth D] Focus chain M [auth F] Focus chain N [auth G]